Subjects of the order are Successive purchases and delivery of medicines for Wielkopolska Rheumatological Center SP SZOZ in Śrem
The object of the order is pharmaceutical products - medicinesThe object of the order is pharmaceutical products - medicines.
Detailed description of the item includes the assortment and price set out in Annex 2.1 to SWZ
Successive Drug Purchases and Supplies to Drug Program — BARICYTINIBSuccessive Drug Purchases and Supplies to Drug Program — BARICYTINIB
Detailed description of the item includes the assortment and price set out in Annex 2.10 to SWZ
Successive purchases and delivery of medicines to the drug program — SEKUKINUMABSuccessive purchases and delivery of medicines to the drug program — SEKUKINUMAB
Detailed description of the item includes the assortment and price set out in Annex 2.11 to SWZ
Successive Purchases and Delivery Immunoglobulin of Human NormalSuccessive Purchases and Delivery Immunoglobulin of Human Normal
Detailed description of the item includes the assortment and price set out in Annex 2.12 to SWZ
Successive Drug Purchases and Supplies to Drug Program — UPADACITINIBSuccessive Drug Purchases and Supplies to Drug Program — UPADACITINIB
Detailed description of the item includes the assortment and price set out in Annex 2.13 to SWZ
Successive Drug Purchases and Supplies to Drug Program — IKSEKIZUMABSuccessive Drug Purchases and Supplies to Drug Program — IKSEKIZUMAB
Detailed description of the item includes the assortment and price set out in Annex 2.14 to SWZ
Successive purchases and delivery of drugs to the drug program — ADALIMUMAB between 1.11.2021 and 31.12.2021Successive purchases and delivery of drugs to the drug program — ADALIMUMAB between 1.11.2021 and 31.12.2021
Detailed description of the item includes the assortment and price set out in Annex 2.15 to SWZ
Successive purchases and supplies of medicines to the drug program — TOFACITINIB between 1.11.2021 and 31.12.2021Successive purchases and supplies of medicines to the drug program — TOFACITINIB between 1.11.2021 and 31.12.2021
Detailed description of the item includes the assortment and price set out in Annex 2.16 to SWZ
Successive purchases and delivery of drugs to the drug program — TOCILIZUMAB.Successive purchases and delivery of drugs to the drug program — TOCILIZUMAB.
Detailed description of the item includes the assortment and price set out in Annex 2.2 to SWZ
Successive Drug Purchases and Supplies to Drug Program — ETARNECEPTSuccessive Drug Purchases and Supplies to Drug Program — ETARNECEPT
Detailed description of the item includes the assortment and price set out in Annex 2.3 to SWZ
Successive purchases and delivery of drugs to the drug program — CERTOLIZUMAB.Successive purchases and delivery of drugs to the drug program — CERTOLIZUMAB.
Detailed description of the item includes the assortment and price set out in Annex 2.4 to SWZ
Successive purchases and delivery of drugs to the drug program — ADALIMUMAB.Successive purchases and delivery of drugs to the drug program — ADALIMUMAB.
Detailed description of the item includes the assortment and price set out in Annex 2.5 to SWZ
Successive Drug Purchases and Supplies to Drug Program — RITUXYMABSuccessive Drug Purchases and Supplies to Drug Program — RITUXYMAB
Detailed description of the item includes the assortment and price set out in Annex 2.6 to SWZ
Successive Drug Purchases and Supplies to Drug Program — INFLIXIMABSuccessive Drug Purchases and Supplies to Drug Program — INFLIXIMAB
Detailed description of the item includes the assortment and price set out in Annex 2.7 to SWZ
Successive purchases and delivery of drugs to the drug program — GOLIMUMAB.Successive Drug Purchases and Supplies to Drug Program — GOLIMUMAB
Detailed description of the item includes the assortment and price set out in Annex 2.8 to SWZ
Successive Drug Purchases and Supplies to Drug Program — TOFACITINIBSuccessive Drug Purchases and Supplies to Drug Program — TOFACITINIB
Detailed description of the item includes the assortment and price set out in Annex 2.9 to SWZ